For instance, high expression of HIF-1α has been associated with unfavorable responses to treatment in hepatocellular carcinoma undergoing local ablation therapies, as well as in oral cancer and locally advanced head and neck squamous cell carcinomas treated with cisplatin and radiation therapy [236–238]. Here, HIF1A is linked to hepatocellular carcinoma.